- Home
- / Amneal Pharmaceuticals
Amneal Pharmaceuticals
Stock Price
$8.6
2024-10-29
Market Capitalization
$2.6 B
2024-10-29
Revenue
$3 B
FY, 2025
Amneal Pharmaceuticals Summary
Company Summary
- Overview
- Amneal Pharmaceuticals is a company that specializes in developing, manufacturing, and distributing of generic products which include complex dosage forms in a broad range of therapeutic areas. Its portfolio includes such dosage forms as liquids, topicals, transdermals, injectables, and inhalation products.
- Type
- Public
- Status
- Active
- Founded
- 2002
- HQ
- Bridgewater Township, NJ, US | view all locations
- Website
- https://amneal.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Paul Meister, Chairman
Chintu Patel, Co-Chief Executive Officer, Director
Deb Autor, Director
LocationsView all
18 locations detected
Bridgewater Township, NJ HQ
United States
400 Crossing Blvd 3rd Floor
Branchburg, NJ
United States
131 Chambers Brook Rd
East Hanover, NJ
United States
1 Murray Rd
Glasgow, KY
United States
118 Beaver Trail
Glasgow, KY
United States
40 Aberdeen Dr
Hauppauge, NY
United States
75 Adams Ave
Amneal Pharmaceuticals Financials
Summary Financials
- Revenue (Q1, 2026)
- $722.5M
- Gross profit (Q1, 2026)
- $320.1M
- Net income (Q1, 2026)
- $78.0M
- Cash (Q1, 2026)
- $197.7M
- EBIT (Q1, 2026)
- $141.8M
- Enterprise value
- $5.0B